Literature DB >> 23199535

Status of serum magnesium in type 2 diabetes mellitus with particular reference to serum triacylglycerol levels.

A R Srinivasan1, G Niranjan, V Kuzhandai Velu, Pragnesh Parmar, A Anish.   

Abstract

UNLABELLED: Magnesium (Mg) is the fourth most abundant cation in the body and the second most common intracellular cation. The association between hypomagnesemia and insulin resistance (IR) in diabetes mellitus has been documented earlier. However, we wanted to study whether the extracellular status of magnesium (Mg) could be a biochemical mediator between hypertriacylglycerolemia and diabetes mellitus. AIMS: To find out the probable association among HbA1c, triacylglycerol (TG) and magnesium levels - a predictor of vascular complications in T(2)DM.
MATERIALS AND METHODS: Thirty patients who had attended the diabetic clinics during the period of this study were included. All the samples were analysed for glucose, TG, Mg, and HbA1c. For statistical analysis, SPSS 17 package was used.
RESULTS: Serum TG (236.67*, 195.06) and HbA1C (9.97*, 8.57) levels were independently compared between the two groups and were significantly high in group A subjects (Mg<1.2mg/dl) as compared to group B subjects (Mg>1.2mg/dl) (*p-value<0.05), respectively. DISCUSSION AND
CONCLUSION: Hypertriacylglycerolemia was pronounced in type 2 diabetes mellitus patients with accompanying hypomagnesemia. This compared well with that of the glycemic control. Low Mg levels, high TG levels in association with enhanced HbA1c levels could thus serve as a reliable biochemical indicator of insulin status and action without resorting to the usage of criteria for insulin sensitivity and resistance.
Copyright © 2012 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23199535     DOI: 10.1016/j.dsx.2012.09.001

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  7 in total

1.  Evaluation of Circulating Plasma VEGF-A, ET-1 and Magnesium Levels as the Predictive Markers for Proliferative Diabetic Retinopathy.

Authors:  Gopal Niranjan; A R Srinivasan; K Srikanth; Gowda Pruthu; R Reeta; Ramasamy Ramesh; Rajendiran Anitha; V Mohana Valli
Journal:  Indian J Clin Biochem       Date:  2018-05-03

Review 2.  Crosstalk of Magnesium and Serum Lipids in Dyslipidemia and Associated Disorders: A Systematic Review.

Authors:  Mihnea-Alexandru Găman; Elena-Codruța Dobrică; Matei-Alexandru Cozma; Ninel-Iacobus Antonie; Ana Maria Alexandra Stănescu; Amelia Maria Găman; Camelia Cristina Diaconu
Journal:  Nutrients       Date:  2021-04-22       Impact factor: 5.717

3.  Consequences of hypomagnesemia in type 2 diabetes mellitus patients.

Authors:  Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2014-12-01

4.  Magnesium and diabetes mellitus.

Authors:  Ali Ghorbani; Azar Baradaran
Journal:  J Renal Inj Prev       Date:  2012-09-01

5.  Status of serum magnesium in Egyptian children with type 1 diabetes and its correlation to glycemic control and lipid profile.

Authors:  Doaa Shahbah; Amr Abo El Naga; Tamer Hassan; Marwa Zakaria; Mohamed Beshir; Salah Al Morshedy; Mohamed Abdalhady; Ezzat Kamel; Doaa Abdel Rahman; Lamiaa Kamel; May Abdelkader
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Oral magnesium supplementation improves glycemic control and lipid profile in children with type 1 diabetes and hypomagnesaemia.

Authors:  Doaaa Shahbah; Tamer Hassan; Saeed Morsy; Hosam El Saadany; Manar Fathy; Ashgan Al-Ghobashy; Nahla Elsamad; Ahmed Emam; Ahmed Elhewala; Boshra Ibrahim; Sherief El Gebaly; Hany El Sayed; Hanan Ahmed
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Low serum magnesium levels and diabetic foot ulcers.

Authors:  Sakir Ozgür Keşkek; Sinan Kırım; Adil Karaca; Tayyibe Saler
Journal:  Pak J Med Sci       Date:  2013-11       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.